X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
DEAD

Serial Number

79006517

Owner

BIOFARMA

Attorney

Leslie Bertagnolli

Filing Date

Sep 21, 2004

Add to watchlist:

No watchlists yet
View on USPTO

X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS Trademark

Serial Number: 79006517 • Registration: 3283161

X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS is a trademark filed by BIOFARMA on September 21, 2004. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

BIOFARMA (297 trademarks)

50, rue Carnot
Suresnes cedex 92284 , FR

Entity Type: 03

Trademark Details

Filing Date

September 21, 2004

Registration Date

August 21, 2007

Published for Opposition

June 5, 2007

Cancellation Date

September 22, 2014

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 29, 2015 INNA
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 9, 2015 DENC
DEATH OF INTERNATIONAL REGISTRATION
Apr 9, 2015 DETH
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 28, 2014 INTR
CANCELLED SECTION 71
Mar 28, 2014 C71T
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 21, 2012 TCCA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 3, 2011 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 19, 2008 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 10, 2007 FICS
FINAL DISPOSITION PROCESSED
Dec 10, 2007 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 28, 2007 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 21, 2007 R.PR
PUBLISHED FOR OPPOSITION
Jun 5, 2007 PUBO
NOTICE OF PUBLICATION
May 16, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 5, 2007 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2007 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2007 TEME
ASSIGNED TO LIE
Apr 2, 2007 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2007 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 26, 2007 TCCA
FINAL REFUSAL MAILED
Sep 13, 2006 CNFR
FINAL REFUSAL WRITTEN
Sep 13, 2006 CNFR
AMENDMENT FROM APPLICANT ENTERED
Aug 25, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2006 CRFA
PAPER RECEIVED
Aug 1, 2006 MAIL
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 25, 2006 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 11, 2006 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 11, 2006 OPNR
NON-FINAL ACTION MAILED
Feb 3, 2006 CNRT
NON-FINAL ACTION WRITTEN
Feb 2, 2006 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2005 DOCK
ASSIGNED TO EXAMINER
Nov 29, 2005 DOCK
AMENDMENT FROM APPLICANT ENTERED
Nov 16, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2005 CRFA
PAPER RECEIVED
Oct 31, 2005 MAIL
REFUSAL PROCESSED BY IB
Jun 9, 2005 RFNT
NON-FINAL ACTION MAILED
Apr 25, 2005 CNRT
NON-FINAL ACTION WRITTEN
Apr 22, 2005 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2005 DOCK
NEW APPLICATION ENTERED
Dec 10, 2004 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 9, 2004 REPR